What should I sell?
| Company | Ticker |
 Margin
|
Valuation |
|---|---|---|---|
| Synageva Biopharma Corp | GEVA |
Overvalued by 74%
|
$10.92 |
| EntreMed, Inc. | ENMD |
Overvalued by 74%
|
$0.51 |
| Cytokinetics, Inc. | CYTK |
Overvalued by 74%
|
$0.30 |
| Micromet Inc. | MITI |
Overvalued by 73%
|
$2.88 |
| Neurocrine Biosciences, Inc. | NBIX |
Overvalued by 73%
|
$3.18 |
| BioMimetic Therapeutics, Inc. | BMTI |
Overvalued by 73%
|
$2.49 |
| Abbott Laboratories | ABT |
Overvalued by 73%
|
$9.74 |
| EastPharma Ltd. | EAST |
Overvalued by 72%
|
$0.41 |
| Omeros Corporation | OMER |
Overvalued by 72%
|
$1.31 |
| Osiris Therapeutics, Inc. | OSIR |
Overvalued by 72%
|
$2.92 |
| e-Therapeutics plc | ETX |
Overvalued by 72%
|
£0.10 |
| Alnylam Pharmaceuticals, Inc. | ALNY |
Overvalued by 72%
|
$7.63 |
| Medivation, Inc. | MDVN |
Overvalued by 72%
|
$14.14 |
| Orexigen Therapeutics, Inc. | OREX |
Overvalued by 72%
|
$1.68 |
| Gentium S.p.A. (ADR) | GENT |
Overvalued by 71%
|
$2.50 |
| Smith & Nephew plc (ADR) | SNN |
Overvalued by 71%
|
$16.95 |
| UnitedHealth Group Inc. | UNH |
Overvalued by 70%
|
$9.95 |
| GlaxoSmithKline plc (ADR) | GSK |
Overvalued by 70%
|
$15.24 |
| YM BioSciences Inc. | YM |
Overvalued by 70%
|
$0.86 |
| YM BioSciences Inc. (USA) | YMI |
Overvalued by 70%
|
$0.86 |
| HeartWare International, Inc. | HTWR |
Overvalued by 70%
|
$28.83 |
| Conceptus, Inc. | CPTS |
Overvalued by 70%
|
$9.25 |
| Sucampo Pharmaceuticals, Inc. | SCMP |
Overvalued by 70%
|
$3.00 |
| Clinuvel Pharmaceuticals Limited | CUV |
Overvalued by 70%
|
$0.57 |
| Alexion Pharmaceuticals, Inc. | ALXN |
Overvalued by 69%
|
$31.43 |